Dual mechanisms of rapid expression of anxiety-related behavior in pilocarpine-treated epileptic mice.

A mouse model of epilepsy was generated by inducing status epilepticus (SE) for either 1.5 or 4.5h with pilocarpine to study anxiety-related behaviors, changes in the electroencephalogram of the cerebral cortex and hippocampus, and expression of hippocampal proteins. The viability and rate of success of SE induction were high in C57BL/6N mice but not in C57BL/6J mice. C57BL/6N mice were immotile during the first 2days after SE; however, by the third day, most mice were recovered and exhibited strong anxiety-related behaviors in response to the light/dark preference test and open field test. There was a striking difference in the temporal appearance of anxiety-related behavior between the two SE durations: 1.5h SE mice exhibited strong anxiety-related behavior 3days after SE that gradually attenuated over the next few weeks, whereas 4.5h SE mice exhibited strong anxiety-related behavior 3days after SE that persisted even at nearly 1year after SE. Mice receiving both SE durations exhibited generalized seizures (GS) after SE; however, there was a marked difference in the timing and duration of GS appearance. Mice in the 4.5h SE group exhibited spontaneous GS from 4days to at least 96days after SE. In contrast, mice in the 1.5h SE group exhibited GS only within the first several days after SE; however, epileptic spike clusters continuously appeared in the cerebral cortex and hippocampus for up to twelve days after SE. Among the hippocampal proteins tested, only brain derived-neurotrophic factor (BDNF) exhibited altered expression in parallel with anxiety-related behavior. These results showed the possibility that BDNF expression in the hippocampus might cause anxiety-related behavior in adulthood.

NMDA receptor-dependent recruitment of calnexin to the neuronal plasma membrane.

Calnexin is a molecular chaperone that resides in the endoplasmic reticulum and participates in the folding and assembly of nascent proteins. In the present study, calnexin was found in both synaptic and non-synaptic membrane components of rat brain tissue. Immunohistochemical staining of mouse hippocampal sections revealed the presence of calnexin in the neuronal cell soma, as well as dendrite-enriched regions. Staining of permeabilized cultured rat hippocampal neurons with anti-calnexin antibody produced intense staining throughout the cytoplasm of the cell body and dendrites. In non-permeabilized cells, calnexin was found on the surface of the cell body and dendrites. To further confirm the surface localization of calnexin, cell surface proteins were selectively labeled with a membrane-impermeable biotinylation reagent. Calnexin and other plasma membrane proteins including N-methyl-D-aspartate (NMDA) receptor and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor were biotinylated, and the amount of calnexin on the plasma membrane markedly increased after NMDA receptor activation. These results suggest that a significant fraction of calnexin localizes to the neuronal cell membrane, and that this recruitment is regulated in an NMDA receptor-dependent manner. Moreover, immunoisolation of vesicles revealed co-localization of the AMPA receptor subunit, GluA2, and calnexin in post-endoplasmic reticulum intracellular membrane components. These findings provide support for the hypothesis that calnexin may play a role in NMDA receptor-dependent neuronal functions.